Endovascular stent-graft repair of complicated penetrating atherosclerotic ulcers of the descending thoracic aorta  by Schoder, Maria et al.
Endovascular stent–graft repair of complicated
penetrating atherosclerotic ulcers of the
descending thoracic aorta
Maria Schoder, MD,a Martin Grabenwo¨ger, MD,b Thomas Ho¨lzenbein, MD,c Hans Domanovits, MD,d
Dominik Fleischmann, MD,a Florian Wolf, MD,a Manfred Cejna, MD,a and Johannes Lammer, MD,a
Vienna, Austria
Objective: To report our initial experience with endovascular stent–graft repair of complicated penetrating atherosclerotic
ulcers as an alternative to surgery in patients with increased risk of perioperative morbidity and mortality.
Method: During a 2-year period, eight patients with complicated penetrating atherosclerotic ulcers of the descending
thoracic aorta were treated with the Gore Excluder stent-graft. Patients (mean age, 70.6 years) presented with two to five
comorbid conditions causing an increased risk for surgical repair. In addition to painful events, three patients presented
with severe hemoptysis, one patient with shortness of breath, and one patient with dysphagia. All patients underwent
emergency computed tomography, and diagnosis of contained rupture was confirmed in five patients. Computed
tomographic findings included one to three penetrating ulcers per patient (n  4), pseudoaneurysms (n  5), additional
intramural hematomas (n  4), mediastinal bleeding (n  2), and hematothoraces (n  4). Through an iliac or femoral
access site, a total of 11 stent–grafts were implanted under general (n 5), epidural (n 2), or spinal (n 1) anesthesia.
Results: Deployment of stent–grafts was successful in all patients, and all sites of hemorrhage were sealed. The intramural
hematoma resolved completely in three cases, and two pseudoaneurysms decreased in size. Intentional occlusion of the
origin of left subclavian artery with the stent–graft in one patient was tolerated without left arm or cerebral symptoms.
One patient experienced permanent paraplegia immediately after endovascular repair. There were no deaths during the
hospital stay (range, 7-35 days; mean, 14.5 days). One patient was lost to follow-up after hospital discharge. The clinical
observation period for the remaining seven patients was 38 to 99 weeks (mean, 60 weeks).
Conclusions: Endovascular stent–graft repair in complicated penetrating atherosclerotic ulcers is an alternative therapeu-
tic option to conventional thoracotomy, especially in patients at high risk of increased morbidity and mortality
perioperatively and postoperatively. (J Vasc Surg 2002;36:720-6.)
Penetrating atherosclerotic ulcers proceed from an ath-
eromatous lesion that penetrates the elastic lamina and
extends into the aortic media, as first described by Shen-
nan1 in 1934. Subsequently, the penetrating ulcer can lead
to intramural hematoma (IMH), localized dissection, pseu-
doaneurysm, and finally rupture.2-12 Penetrating ulcers
typically present with sudden onset of thoracic or back pain
in elderly patients with hypertension and atherosclerotic
disease, mimicking aortic dissection. Furthermore, the ini-
tial clinical symptoms could be the result of ischemia in
peripheral vessels caused by embolism from intimal ulcer-
ation.5
Early surgical intervention in symptomatic penetrating
ulcers is recommended.2,6,12 Nevertheless, this population
of patients has a high incidence of comorbidity and, there-
fore, conventional open repair requiring graft interposition
is associated with high morbidity and mortality rates, par-
ticularly in complicated ulcers (ie, intramural hematoma,
pseudoaneurysm, or rupture).
Less invasive strategies for the treatment of aortic an-
eurysms with endovascular techniques have shown promis-
ing results in elective thoracic aneurysm repair13-22 and
emergency repair of acute rupture of the thoracic aor-
ta.16,19,21,23-25
The purpose of this article is to report our initial
experience with endovascular repair of symptomatic pene-
trating ulcers, including five patients with signs of rupture.
PATIENTS AND METHODS
Patients. From April 1999 to March 2001, three
female and five male symptomatic patients with penetrating
atherosclerotic ulcers of the descending thoracic aorta were
treated with endovascular stent–graft repair. Patient age
ranged from 52 to 84 years (mean, 70.6 years). Written
informed consent was obtained from all patients.
All patients were initially seen in the emergency depart-
ment, where adequate intravenous access was obtained for
fluid replacement or administration of medication. In ad-
dition to chest pain (n 7) and epigastric pain (n 1), the
clinical symptoms included severe hemoptysis (n  3),
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shortness of breath (n  1), and severe dysphagia (n  1).
On admission, one patient was hemodynamically unstable;
the mean hematocrit level was 30.8% (range, 21.3%-
36.3%), and the mean hemoglobin was 10.2 g/dL (range,
7.2-12.0 g/dL). The medical history included cardiac dis-
ease, with coronary artery disease in three patients, or prior
aortic valve replacement because of aortic regurgitation,
grade I and II in two patients. Further comorbid conditions
were hypertension (n  7), impaired renal function (n 
4), chronic obstructive pulmonary disease (n 4), diabetes
type II (n  3), and history of stroke (n  2). Patient
characteristics, appearance of the atherosclerotic ulcer, and
concomitant computed tomographic findings are listed in
Table I.
The thoracoabdominal aorta was evaluated by contrast-
enhanced helical computed tomography using a standard
protocol. Those patients with contained rupture had an
ulcer complicated by formation of a false aneurysm (four
patients) (Fig 1, A), and an intramural hematoma (IMH)
(one patient) (Fig 2, A). Measurements for evaluation for
stent–graft therapy, as well as planning of the access site,
were based upon the preoperative computed tomographic
scans in all patients. An additional angiography with a
calibrated pigtail catheter (Cook Australia, Brisbane, Aus-
tralia) was performed in three patients. The diameter of the
stent–graft was calculated from the largest diameter of the
proximal or distal neck of the aneurysm and an oversizing
factor of 10% to 20%.
Because of hemodynamic instability, one patient was
transferred to the angiography suite immediately after com-
puted tomographic examination. Hemodynamically stable
patients were transferred to the intensive care unit until the
appropriate sized stent–graft was available.
Stent–graft procedure. In our department, endovas-
cular stent–graft repair is always performed by an interdis-
ciplinary team, including anesthesiologists, surgeons, and
interventional radiologists. All procedures were performed
in the angiography suite, which is equipped with digital
substraction angiography (Multistar T.O.P., Siemens, Er-
langen, Germany) with an overlay imaging technique.
Treatment was performed under general anesthesia (n 
5), epidural anesthesia (n 2), or spinal anesthesia (n 1).
Patients were fully monitored, including use of a central
venous access and a radial artery line.
Depending on the size of the introducer sheath (22 or
24 French), the access site was created by surgical arteriot-
omy of the common femoral artery (n  3), external iliac
artery (n  1), common iliac artery (n  3), or the limb of
a bifurcated aortoiliac endoprosthesis (n  1). After surgi-
cal preparation of the artery, an 8 French vascular sheath
was introduced over an 0.035 in standard guide wire (Bent-
son, Boston Scientific International, Galway, Ireland). Fol-
lowing the diagnostic angiography, a super stiff guide wire
(Back-up Meier, Boston Scientific Corp, Natick, Mass) was
placed in the aortic arch. The right or left brachial artery
was accessed percutaneously to enable a control angiogra-
Table I. Patients characteristics, morphologic appearance of penetrating atherosclerotic ulcers, and additional
CT findings
Patient
No. Age/sex Symptoms
Number of
comorbidities Location of ulcer Morphology
Lesion size,
depth (mm) Additional CT finding(s)
1 83.9/M Chest pain, severe
hemoptysis
2 Distal third DTA Saccular/false
aneurysm
55 Partially consolidated left
lower lobe, hemothorax
2 74.2/M Chest pain, severe
hemoptysis
3 Distal third DTA Saccular/false
aneurysm
30 Parenchymal lung opacities
3 66.7/M Chest pain,
recurrent
hemoptysis
5 Distal third DTA Saccular/false
aneurysm
58 Hematothorax,
parenchymal lung
opacities, partially
consolidated left lower
lobe
4 84.4/M Chest pain,
shortness of
breath
3 Middle third DTA Two ulcers 10/7 Hematothorax, mediastinal
bleeding, partially
consolidated left lower
lobe, IMH (maximum
width, 1.3 cm)
5 57.0/M Chest pain, severe
dysphagia
2 Proximal third DTA Saccular/false
lobulated
aneurysm
107 Hematothorax, mediastinal
bleeding, displacement/
compression of
esophagus
6 80.7/F Chest pain 2 Proximal third DTA Single ulcer,
saccular/false
aneurysm
15/26 IMH (maximum width,
1.8 cm) Partial widening
of the proximal third
and thoracoabdominal
segment of DTA
7 78.4/F Epigastric pain 3 Proximal third DTA Single ulcer 9 IMH (maximum width,
1.5 cm)
8 58.1/F Chest pain 5 Distal third DTA Three ulcers 22/10/8 IMH (maximum width 1.0
cm)
CT, computed tomography; DTA, descending thoracic aorta; IMH, intramural hematoma.
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phy immediately before stent–graft deployment (Fig 1, B).
Before introduction of the stent–graft system, 3000 to
5000 IU heparin sodium was administered intravenously,
and antibiotic medication was given prophylactically. The
Gore Excluder endoprosthesis (W.L. Gore & Associates,
Flagstaff, Ariz) was used for all procedures. Detailed con-
struction and deployment procedure for this stent-graft has
been described previously.11 Because of occasional break-
age of the longitudinal spines the Gore Excluder, thoracic
endoprosthesis is currently withdrawn from the market for
reevaluation and redesign of the longitudinal support sys-
tem. Routinely, contrast-enhanced spiral computed to-
mography was performed on all patients before hospital
discharge, after 3, 6, and 12 months, and yearly thereafter.
RESULTS
Procedural results. Emergent stent–graft repair was
performed in six patients. The interval between arrival of
the patient at the emergency room and start of the stent–
graft procedure varied from 2 hours to 67 hours (mean, 33
hours). For all stent–graft implantations, the mean proce-
dure time was 151 minutes (range, 95-235 minutes), and
the amount of contrast medium used ranged from 100 mL
to 215 mL (mean, 149 mL).
The deployment of the stent–graft was technically suc-
cessful in all patients. During deployment, distal migration
of the endoprosthesis occurred in one patient. Neverthe-
less, the leak was treated successfully by placement of an
Fig 1. A, Contrast-enhanced computed tomographic scan showing a partially thrombosed pseudoaneurysm.
B, Digital subtraction angiography before stent–graft insertion allows precise delineation of the false aneurysm.
C, Completion of angiogram after stent–graft deployment documents successful exclusion of the pseudoaneurysm.
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additional stent–graft proximal to the first placement. To
bridge the total length of the IMH, two endoprostheses
were needed for another two patients.
The saccular false aneurysm in one patient was close to
the orifice of the left subclavian artery, and, therefore, the
stent–graft was placed intentionally across the subclavian
artery with total occlusion of the orifice. However, suffi-
cient collateral filling through a patent right and left verte-
bral artery was documented angiographically. In a second
patient, the orifice of the subclavian artery was partially
covered by the stent–graft. Completion angiograms after
procedures showed correct position of the stent–grafts
without suspicion of a perigraft leak (Fig 1, C) in any
patient.
Clinical result and follow-up. None of the patients
had symptoms of rebleeding during the postoperative pe-
riod. The dysphagia of one patient resolved soon after
stent–graft placement. The two patients with a partially or
totally covered origin of the left subclavian artery remained
free of ischemic posterior circulation symptoms and arm
ischemia. One patient who had a pseudoaneurysm in the
distal third of the descending thoracic aorta experienced
permanent paraplegia. Two of the patients with an aorto-
bronchial fistula and preoperative consolidation of the left
lower lung lobe developed fever, leukocytosis, and elevated
C-reactive protein level in the postinterventional period,
resulting in a prolonged hospital stay of 35 days in one
patient. Signs of inflammation resolved completely after
antibiotics were given for 2 and 6 weeks, respectively. The
mean hospital stay was 14.5 days (range, 7-35 days), and
the mean stay in the intensive care unit was 2.5 days (range,
1-5 days).
At the first postoperative computed tomographic ex-
amination performed 5 to 7 days after the procedure, all
stent–grafts were in the correct position. Complete cover-
ing of the entire length of the IMH or the false aneurysm as
attempted was achieved in all cases. One patient who had a
concomitant partial widening of the proximal third and the
thoracoabdominal segment of the descending thoracic
aorta presented with a small perigraft leak in the ectatic
proximal segment caused by an intercostal artery that sealed
spontaneously at the 3-month follow-up. The same patient
had a slight decrease of the false aneurysm at the lateral site
of the descending thoracic aorta of 0.5 cm (from 2.6-2.1
cm), but an increase in the aortic diameter distal to the
stent–graft at the 1 year follow-up (from 4.2-5.5 cm). At
the 6- and 12-month computed tomographic follow-up
examinations, the IMH in three patients had resolved com-
pletely (Fig 2 B,C), and in another patient there was a
decrease in the diameter of the false aneurysm of 4.7 cm
(from 5.8 to 1.1 cm). Two patients had 1- and 3-month
computed tomography follow-up showing no endoleak
and unchanged aneurysm sizes.
The mean clinical observation time for seven patients
(one patient was lost to follow-up) was 423 days (range,
264-690 days). During this period, one patient presented
with recurrent symptoms of thoracic aortic disease. The
patient, who had a decrease in the size of his false aneurysm
(from 5.8 to 1.1 cm) at the one-year computed tomogra-
phy follow-up experienced a massive recurrence of hemop-
Fig 2. Two-dimensional reconstructions of contrast-enhanced computed tomographic scans. A, Preprocedural
computed tomographic scan showing a distinct ulcer crater in the proximal segment of descending thoracic aorta and
an intramural hematoma. B, Seven days postoperatively, exclusion of the ulcer is documented; orifice of subclavian
artery was partially covered by the stent–graft. C, Six months postoperatively, the intramural hematoma has resolved
completely.
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tysis 23 months after the procedure, which resulted in
death. Postmortem examination revealed an aortobron-
chial fistula caused by recurrent increase of the saccular
aneurysm despite an intact stent–graft. Postmortem exam-
ination showed that the proximal and distal ends of the
stent–graft were slightly attached to the aortic wall with no
macroscopic signs of gross graft infection. Therefore, we
speculate that the fatal hemoptysis was possibly the result of
an undetected or newly developed proximal or distal type 1
endoleak, or a type 2 endoleak over a patent bronchial
artery that was not detected with computed tomography.
The deaths of two other patients (days 357 and 435) were
not related to thoracic aortic disease.
DISCUSSION
Ulceration of an atheromatous plaque, confined to the
intimal layer, usually remains asymptomatic. Once formed,
the ulcer may remain quiescent or the process may progress
with penetration through the internal elastic lamina, allow-
ing formation of an intramural hematoma2-11 and a variable
degree of aortic dissection. Furthermore, the ulcer may
penetrate the full thickness of the media, resulting in false
aneurysms,2,4,7-8,10 imminent fistulation into adjacent or-
gans, or even free rupture.2-4,6-8,10 Patients are typically
elderly with hypertension and diffuse systemic atheroscle-
rosis.2,4,5-7 They often present clinically with acute chest or
back pain that mimics aortic dissection.2,4,6 In our study
cohort, all patients presented with pain. The most frequent
locations and natural course of penetrating atherosclerotic
ulcers found in the literature are listed in Table II. More-
over, some investigators have found that the prevalence of
a critical course with progression of the lesion and rupture
is higher in atherosclerotic penetrating ulcers than in classic
aortic dissections.2,6,12 At the time of diagnosis, five of
eight (63%) of our patients had signs of rupture with
hemoptysis, bloody pleural effusion, or mediastinal bleed-
ing.
Table II. Frequent locations and natural course of penetrating atherosclerotic ulcers
Reference Year
No. of
patients
Mean
age
(y)
Chest/
back
pain
Site of ulcer
of TA
IMH or
localized
dissection
False
aneurysm
Recurrent
pain
Progression
of lesion Rupture
Treatment
surgical/
stent–graft
Stanson et al2 1986 16 73 13 22 lesions: 14 2 7 NA 7 14/0
1 ascending TA
5 proximal TA
7 middle TA
8 distal TA
1 subclavian artery
Yucel et al3 1990 7 70 7 TA 6 0 0 0 1 3/0
Kazerooni et al4 1992 16 74 13 2 proximal TA 16 1 6 4 1 7/0
14 middle/distal
TA
Harris et al5 1994 18 74 4 29 lesions:
1 arch TA
4 proximal TA
5 middle TA
9 distal TA
10 AA
67% of
lesions
NA 2 8/17
lesions
0 2/0
Coady et al6 1998 15 77 12 2 ascending TA 2 NA 0 3 6 4/0
13 descending TA
Vilacosta et al7 1998 12 65 12 2 ascending TA 5 2 0 5 3 5/0
3 arch TA
7 descending TA
Murgo et al8 1998 4 76 4 4 middle/distal
descending TA
4 1 NA NA 1 0/4
Brittenden et al9 1999 2 72 2 2 middle descending
TA
1 0 0 NA 0 0/2
Hayashl et al10 2000 12 72 NA 6 proximal
descending TA
1 1 4 4 2 4/0
5 distal descending
TA
1 AA
Quint et al11 2001 38 72 21 56 lesions:
1 ascending TA
14 arch TA
15 proximal
descending TA
20 distal descending
TA
6 AA
22 NA 2 10/33
lesions
0 4/2
AA, Abdominal aorta; NA, not available; TA, thoracic aorta.
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Some investigators believe that immediate surgical
treatment is not always required because most ulcers re-
main unchanged or progress slowly.4,5,11 However, symp-
tomatic patients with signs of impending rupture (ie, pseu-
doaneurysm formation, or pericardial or bloody pleural
effusion), free rupture, persistent pain, and embolization
have been considered as indications for expeditious surgical
treatment.2-11
Surgical repair of the descending thoracic aorta for
treatment of a variety of aortic diseases has become a
relatively safe procedure in terms of survival and spinal cord
injuries. The perioperative mortality rate including patients
with involvement of the complete descending aorta varied
from 3% to 13%.26-32 Reported mortality rates in patients
with emergent surgical repair are quite different and range
from 6.9% to 60%.26,28,32 Furthermore, spinal cord injury
rates with postoperative paraplegia/paraparesis range from
zero to 8.3%.26-32 However, respiratory complications and
renal failure represent the most frequent morbidity, re-
ported between 5.3% to 33%26,28-31 and 2.5% to
13.3%26,28-32, respectively.
Endovascular stent–graft therapy has become a less
invasive alternative therapy for thoracic aortic aneurysm
repair, especially in elderly patients who present frequently
with comorbidities including hypertension, coronary and
carotid artery disease, renal insufficiency, and chronic ob-
structive pulmonary disease, thereby increasing the risk of
perioperative mortality and morbidity. Stent–grafts have
been used successfully in elective and emergency set-
tings.13-25 The perioperative mortality rates are between
zero and 12.5% in elective stent–graft procedures, and
between zero and 33% in emergent stent–graft set-
tings.16,19,21,23-25 Paraplegia/paraparesis was a complica-
tion that had not occurred in most series, but permanent
paraplegia has been reported in up to 4%.15,19
To date, there are only few reports addressing specifi-
cally endovascular repair of penetrating atherosclerotic ul-
cers.8,9,11
Murgo et al8 reported a successful stent–graft deploy-
ment in four patients with atherosclerotic ulcers that were
complicated in three cases by either retrograde dissection,
false aneurysm, or rupture. There was no death within the
30-day perioperative period. However, one patient experi-
enced transient paraparesis. One patient had a mild peri-
graft leak that resolved during the first month. In a second
patient, a new circulating false lumen proximal to the
prosthesis was detected by computed tomographic scan
four days after the treatment, and was sealed with a second
stent–graft. In another patient, a new progressively grow-
ing false aneurysm in the upper third of the unstented
descending thoracic aorta was demonstrated at computed
tomographic scanning performed 3 and 4 months after the
procedure. This patient refused further intervention and
died from unknown causes 6 months after the procedure.
Brittenden et al9 reported two patients with penetrat-
ing ulcers who were treated successfully with stent–graft
therapy. Both patients had hematothoraces, and, in one
case, an additional small dissection flap and an intramural
hematoma. At the 1-year follow-up, both patients re-
mained well. Mitchell et al14 reported a series of 44 patients
treated with stent–grafts, eight of whom presented with an
intramural hematoma or an ulcer. There are only a few
small series reporting results after surgical repair of athero-
sclerotic penetrating ulcers. Perioperative mortality rates
range from 7.1% to 25%,2,4,6 and a neurologic deficit
occurred in up to 28.6%.2
Penetrating ulcers can be complicated by pseudoaneu-
rysms with aortobronchial fistulas that can result in life-
threatening hemoptysis. To date, there have been several
case reports of successful sealing of aortobronchial fistulas
by use of stent–graft therapy.24,25,33-35 Most of these
pseudoaneurysms in the descending thoracic aorta were of
postoperative origin, and occasionally the result of a my-
cotic aneurysm, but in no case was the fistula caused by a
false aneurysm resulting from a penetrating ulcer.
Five cases with penetrating atherosclerotic ulcers in our
study cohort were complicated by pseudoaneurysms, which
resulted in aortopulmonary fistulas in three patients, a
contained rupture with bloody pleural effusion and medi-
astinal bleeding in one, and an additional IMH in another
one of these cases. The remaining three patients presented
with varying degrees of IMH with an additional localized
dissection in one and signs of bleeding in a second of this
group. Despite ruptures in five patients and additional
hemodynamic instability in one case, we had no perioper-
ative death. We had two patients with a short proximal
aneurysm neck that necessitated partial or total stent–graft
placement across the subclavian artery. These two patients
tolerated coverage of the subclavian artery without arm
ischemia or ischemic posterior circulation symptoms.
Therefore, we agree with the statement by Dake36 that a
prophylactic transposition of the subclavian artery must not
be forced. However, in our opinion it is mandatory to
document angiographically a sufficient collateral pathway
through both vertebral arteries before stent–graft deploy-
ment.
In conclusion, endovascular stent–graft repair of com-
plicated atherosclerotic ulcers of the descending thoracic
aorta is technically feasible with a low mortality rate. How-
ever, in view of our small number of patients, the risk of
paraplegia remains unknown. Although, to evaluate patient
populations that benefit most from endovascular repair and
long-term durability of this procedure further controlled
trials are necessary.
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